BioSpace

Novo CEO Fires Back at Pfizer From White House: ‘Put Your Hand in Your Pocket’

During a press conference to announce a drug price deal for GLP-1s, President Donald Trump asked for more details about the ...

Pfizer wins obesity drug prize, with Trump administration assist

Pfizer Chief Executive Albert Bourla had long searched for an obesity drug to make up for dwindling sales of the pharma ...

The Top 5 Analyst Questions From Pfizer’s Q3 Earnings Call

Pfizer’s third quarter results reflected ongoing challenges in its COVID-19 franchise, but management pointed to solid growth ...

Novo Nordisk CEO faces baptism of fire amid board shakeup, Pfizer fight

Novo Nordisk's new CEO is set to face intense investor scrutiny this week as the Wegovy-maker shakes up its board and pursues ...
BioSpaceOpinion

Novo’s CEO Doesn’t Seem To Mind Being Big Pharma’s Villian

But Doustdar also seems to recognize what he has in Novo Nordisk, the 100-year-old pharma that brought insulin to the masses, ...

Pfizer Metsera Acquisition: What It Means for Patients and the Future of Weight Loss

Pfizer wins the $10B bid for Metsera, opening new avenues for obesity treatment and addressing unmet healthcare needs with ...

Pfizer shows hardball mettle needed to win in 2025 M&A

Pharma giant had to pay a blockbuster price to buy Metsera after the biotech prospect spurred an auction with Novo Nordisk ...
Labiotech.eu

Novo Nordisk’s pipeline plan: How the pharma giant is refocusing amid major restructuring

Discover how Novo Nordisk's pipeline is being restructured to refocus its efforts on high-growth areas like diabetes and ...